358 related articles for article (PubMed ID: 36225133)
1. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
[TBL] [Abstract][Full Text] [Related]
2. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
[TBL] [Abstract][Full Text] [Related]
3. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
[TBL] [Abstract][Full Text] [Related]
4. Differentiated HIV services for transgender people in four South African districts: population characteristics and HIV care cascade.
Bothma R; O'Connor C; Nkusi J; Shiba V; Segale J; Matsebula L; Lawrence JJ; van der Merwe LL; Chersich M; Hill N
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25987. PubMed ID: 36225147
[TBL] [Abstract][Full Text] [Related]
5. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
[TBL] [Abstract][Full Text] [Related]
6. PrEP for women in Europe: a systematic literature review.
Fitzgerald N; Coltart H; Dominguez L; Flanagan K; Gilleece Y
HIV Med; 2023 Jul; 24(7):765-776. PubMed ID: 37088558
[TBL] [Abstract][Full Text] [Related]
7. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
[TBL] [Abstract][Full Text] [Related]
8. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
Sevelius JM; Deutsch MB; Grant R
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21105. PubMed ID: 27760683
[TBL] [Abstract][Full Text] [Related]
9. HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.
Oldenburg CE; Le B; Toan T; Thien DD; Huyen HT; Friedman MR; Stall R; Colby D
AIDS Behav; 2016 Dec; 20(Suppl 3):365-370. PubMed ID: 27435073
[TBL] [Abstract][Full Text] [Related]
10. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users.
Nieto O; Fehrenbacher AE; Cabral A; Landrian A; Brooks RA
AIDS Care; 2021 Feb; 33(2):244-252. PubMed ID: 32449399
[TBL] [Abstract][Full Text] [Related]
11. Understanding Barriers and Facilitators of Pre-exposure Prophylaxis (PrEP) Among Transgender and Gender Diverse Adults in an Integrated Health Care System.
Bruxvoort K; Portugal C; Munis M; Pak K; Hechter R
AIDS Behav; 2023 Aug; 27(8):2579-2591. PubMed ID: 36650390
[TBL] [Abstract][Full Text] [Related]
12. "Entre Nosotras:" a qualitative study of a peer-led PrEP project for transgender latinas.
Zamudio-Haas S; Koester K; Venegas L; Salinas A; Herrera C; Gutierrez-Mock L; Welborn L; Deutsch MB; Sevelius J
BMC Health Serv Res; 2023 Sep; 23(1):1013. PubMed ID: 37730598
[TBL] [Abstract][Full Text] [Related]
13. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
Cahill SR; Keatley J; Wade Taylor S; Sevelius J; Elsesser SA; Geffen SR; Wang T; Mayer KH
AIDS Care; 2020 May; 32(5):585-593. PubMed ID: 31482726
[TBL] [Abstract][Full Text] [Related]
14. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
[TBL] [Abstract][Full Text] [Related]
15. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
[TBL] [Abstract][Full Text] [Related]
16. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study.
Janamnuaysook R; Guo Y; Yu YJ; Phanuphak N; Kawichai S; MacDonell K; Jupimai T; Rongkavilit C; Wang B
Sex Health; 2024 Jan; 21():. PubMed ID: 38219741
[TBL] [Abstract][Full Text] [Related]
17. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Sevelius JM; Keatley J; Calma N; Arnold E
Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
[TBL] [Abstract][Full Text] [Related]
19. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
[TBL] [Abstract][Full Text] [Related]
20. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial.
Irungu EM; Mugwanya KK; Mugo NR; Bukusi EA; Donnell D; Odoyo J; Wamoni E; Peacock S; Morton JF; Ngure K; Mugambi M; Mukui I; O'Malley G; Baeten JM;
Lancet Glob Health; 2021 Dec; 9(12):e1730-e1739. PubMed ID: 34798031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
